FindTrial
Sign In

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2012-001247-51-FI
Enrollment
Unknown
Registered
2012-05-07
Start date
2012-06-04
Completion date
Unknown
Last updated
2014-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

MedDRA version: 14.1 Level: LLT Classification code 10006028 Term: Borderline glaucoma (glaucoma suspect) System Organ Class: 10015919 - Eye disorders MedDRA version: 14.1 Level: LLT Classification code 10037118 Term: Pseudoexfoliation glaucoma System Organ Class: 10015919 - Eye disorders MedDRA version: 14.1 Level: LLT Classification code 10036675 Term: Primary angle-closure glaucoma System Organ Class: 10015919 - Eye disorders

Interventions

Trade Name: NATRIUMKLORID BRAUN 234 mg/ml infuusiokonsentraatti Product Name: Natriumkloridi Braun 234 mg/ml liuos Pharmaceutical Form: Solution for injection/infusion CAS Number: 7647-14-5 Other desc

Sponsors

Mika Harju
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range 20 F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range 19

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Main Objective: ;Secondary Objective: ;Primary end point(s):—

Countries

Finland

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026